Sun Jian, Zhao Yilin, McGreal Rebecca, Cohen-Tayar Yamit, Rockowitz Shira, Wilczek Carola, Ashery-Padan Ruth, Shechter David, Zheng Deyou, Cvekl Ales
Department of Genetics, Albert Einstein College of Medicine, Bronx, NY 10461 USA.
Department of Genetics, Albert Einstein College of Medicine, Bronx, NY 10461 USA ; Department of Ophthalmology and Visual Sciences, Albert Einstein College of Medicine, Bronx, NY 10461 USA.
Epigenetics Chromatin. 2016 Sep 9;9(1):37. doi: 10.1186/s13072-016-0087-z. eCollection 2016.
Pax6 is a key regulator of the entire cascade of ocular lens formation through specific binding to promoters and enhancers of batteries of target genes. The promoters and enhancers communicate with each other through DNA looping mediated by multiple protein-DNA and protein-protein interactions and are marked by specific combinations of histone posttranslational modifications (PTMs). Enhancers are distinguished from bulk chromatin by specific modifications of core histone H3, including H3K4me1 and H3K27ac, while promoters show increased H3K4me3 PTM. Previous studies have shown the presence of Pax6 in as much as 1/8 of lens-specific enhancers but a much smaller fraction of tissue-specific promoters. Although Pax6 is known to interact with EP300/p300 histone acetyltransferase responsible for generation of H3K27ac, a potential link between Pax6 and histone H3K4 methylation remains to be established.
Here we show that Pax6 co-purifies with H3K4 methyltransferase activity in lens cell nuclear extracts. Proteomic studies show that Pax6 immunoprecipitates with Set1a, Mll1, and Mll2 enzymes, and their associated proteins, i.e., Wdr5, Rbbp5, Ash2l, and Dpy30. ChIP-seq studies using chromatin prepared from mouse lens and cultured lens cells demonstrate that Pax6-bound regions are mostly enriched with H3K4me2 and H3K4me1 in enhancers and promoters, though H3K4me3 marks only Pax6-containing promoters. The shRNA-mediated knockdown of Pax6 revealed down-regulation of a set of direct target genes, including Cap2, Farp1, Pax6, Plekha1, Prox1, Tshz2, and Zfp536. Pax6 knockdown was accompanied by reduced H3K4me1 at enhancers and H3K4me3 at promoters, with little or no changes of the H3K4me2 modifications. These changes were prominent in Plekha1, a gene regulated by Pax6 in both lens and retinal pigmented epithelium.
Our study supports a general model of Pax6-mediated recruitment of histone methyltransferases Mll1 and Mll2 to lens chromatin, especially at distal enhancers. Genome-wide data in lens show that Pax6 binding correlates with H3K4me2, consistent with the idea that H3K4me2 PTMs correlate with the binding of transcription factors. Importantly, partial reduction of Pax6 induces prominent changes in local H3K4me1 and H3K4me3 modification. Together, these data open the field to mechanistic studies of Pax6, Mll1, Mll2, and H3K4me1/2/3 dynamics at distal enhancers and promoters of developmentally controlled genes.
Pax6通过与一系列靶基因的启动子和增强子特异性结合,成为整个晶状体形成级联反应的关键调节因子。启动子和增强子通过由多种蛋白质-DNA和蛋白质-蛋白质相互作用介导的DNA环化相互沟通,并以组蛋白翻译后修饰(PTM)的特定组合为特征。增强子通过核心组蛋白H3的特定修饰与大量染色质区分开来,包括H3K4me1和H3K27ac,而启动子则显示H3K4me3 PTM增加。先前的研究表明,Pax6存在于多达1/8的晶状体特异性增强子中,但在组织特异性启动子中的比例要小得多。尽管已知Pax6与负责生成H3K27ac的EP300/p300组蛋白乙酰转移酶相互作用,但Pax6与组蛋白H3K4甲基化之间的潜在联系仍有待确定。
我们在此表明,Pax6在晶状体细胞核提取物中与H3K4甲基转移酶活性共同纯化。蛋白质组学研究表明,Pax6与Set1a、Mll1和Mll2酶及其相关蛋白(即Wdr5、Rbbp5、Ash2l和Dpy30)免疫沉淀。使用从小鼠晶状体和培养的晶状体细胞制备的染色质进行的ChIP-seq研究表明,Pax6结合区域在增强子和启动子中大多富含H3K4me2和H3K4me1,尽管H3K4me3仅标记含Pax6的启动子。shRNA介导的Pax6敲低揭示了一组直接靶基因的下调,包括Cap2、Farp1、Pax6、Plekha1、Prox1、Tshz2和Zfp536。Pax6敲低伴随着增强子处H3K4me1和启动子处H3K4me3的减少,而H3K4me2修饰几乎没有变化。这些变化在Plekha1中很明显,Plekha1是一个在晶状体和视网膜色素上皮中均受Pax6调节的基因。
我们的研究支持Pax6介导组蛋白甲基转移酶Mll1和Mll2募集到晶状体染色质的一般模型,尤其是在远端增强子处。晶状体中的全基因组数据表明,Pax6结合与H3K4me2相关,这与H3K4me2 PTM与转录因子结合相关的观点一致。重要的是,Pax6的部分减少会引起局部H3K4me1和H3K4me3修饰的显著变化。总之,这些数据为发育控制基因远端增强子和启动子处Pax6、Mll1、Mll2和H3K4me1/2/